Searched for
KRAS INHIBITOR
Pancreatic cancer drug daraxonrasib touted as ‘biggest leap forward’ in decades after controlling disease in 90% of patientsPancreatic cancer drug daraxonrasib: Daraxonrasib has emerged as a promising treatment for advanced pancreatic cancer, showing remarkable r...
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...